Andreas Roidl

1.0k citations

27 papers · 817 indexed · h-index 15

Impact in

Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Molecular Biology
- Fibroblast Growth Factor Research
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Interference and Gene Delivery

Papers in ⓘ

Cancer Research 11
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 3
Toxicology 1

Co-authors: Ernst Wagner (20 shared papers)Florian Kopp (6 shared papers)Prajakta Oak (4 shared papers)Adam Hermawan (6 shared papers)Wolfhard Bandlow (1 shared paper)Pjotr Knyazev (4 shared papers)Axel Ullrich (2 shared papers)Sushil Kumar (1 shared paper)
Journals: Scientific Reports (3 papers)Translational Oncology (2 papers)Oncotarget (2 papers)International Journal of Cancer (2 papers)PLoS ONE (2 papers)
Partner nations: Germany United States Netherlands

In The Last Decade

Andreas Roidl

27 papers receiving 810 citations

Peers

Countries citing papers authored by Andreas Roidl

Since Specialization

Citations

This map shows the geographic impact of Andreas Roidl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Roidl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Roidl more than expected).

Fields of papers citing papers by Andreas Roidl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Roidl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Roidl. The network helps show where Andreas Roidl may publish in the future.

Co-authors

The 25 scholars most cited alongside Andreas Roidl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andreas Roidl Line = papers co-authored together Andreas Roidl links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression PLoS ONE ·Florian Kopp, Prajakta Oak, Ernst Wagner, Andreas Roidl	2012	103
2	Resistance to Chemotherapy Is Associated with Fibroblast Growth Factor Receptor 4 Up-Regulation Clinical Cancer Research ·Andreas Roidl, Hans-Jürgen Berger, Sushil Kumar, Johannes Bange, Pjotr Knyazev, Axel Ullrich	2009	81
3	Yeast Rio1p is the founding member of a novel subfamily of protein serine kinases involved in the control of cell cycle progression Molecular Microbiology ·Michaela Angermayr, Andreas Roidl, Wolfhard Bandlow	2002	77
4	Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2‐positive cancer cells and cancer stem cells International Journal of Cancer ·Prajakta Oak, Florian Kopp, Chitra Thakur, Joachim W. Ellwart, Ulf R. Rapp, Axel Ullrich, Ernst Wagner, Pjotr Knyazev, Andreas Roidl	2012	64
5	The proto-oncogene KRAS is targeted by miR-200c Oncotarget ·Florian Kopp, Ernst Wagner, Andreas Roidl	2013	63
6	V-ATPase inhibition by archazolid leads to lysosomal dysfunction resulting in impaired cathepsin B activationin vivo International Journal of Cancer ·Rebekka Kubisch, Thomas Fröhlich, Georg J. Arnold, Laura Schreiner, Karin von Schwarzenberg, Andreas Roidl, Angelika M. Vollmar, Ernst Wagner	2013	55
7	Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration Molecular Cancer ·Florian Kopp, Adam Hermawan, Prajakta Oak, Annika Herrmann, Ernst Wagner, Andreas Roidl	2014	54
8	The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells Oncogene ·Andreas Roidl, Priscilla Foo, Willy Wong, Christian Mann, S Bechtold, Hans-Jürgen Berger, S. Streit, Jens E. Ruhe, Stefan Hart, A. Ullrich, Han Kiat Ho	2009	46
9	Consecutive salinomycin treatment reduces doxorubicin resistance of breast tumor cells by diminishing drug efflux pump expression and activity Oncology Reports ·Adam Hermawan, Ernst Wagner, Andreas Roidl	2015	41
10	EGF receptor targeted lipo-oligocation polyplexes for antitumoral siRNA and miRNA delivery Nanotechnology ·Katharina Müller, Philipp Klein, Philipp Heissig, Andreas Roidl, Ernst Wagner	2016	37
11	A Comprehensive Gene Expression Analysis of Resistance Formation upon Metronomic Cyclophosphamide Therapy Translational Oncology ·Rebekka Kubisch, Lilja Meissner, Stefan Krebs, Helmut Blum, Michael Günther, Andreas Roidl, Ernst Wagner	2013	29
12	MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators The Breast ·Bojan Ljepoja, Jonathan García-Román, Ann‐Katrin Sommer, Ernst Wagner, Andreas Roidl	2018	26
13	Inducible microRNA-200c decreases motility of breast cancer cells and reduces filamin A PLoS ONE ·Bojan Ljepoja, Christoph Schreiber, Florian Gegenfurtner, Jonathan García-Román, Bianca Köhler, Stefan Zahler, Joachim O. Rädler, Ernst Wagner, Andreas Roidl	2019	19
14	Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases Oncotarget ·Ann‐Katrin Sommer, Adam Hermawan, Frauke Martina Mickler, Bojan Ljepoja, Pjotr Knyazev, Christoph Bräuchle, Axel Ullrich, Ernst Wagner, Andreas Roidl	2016	17
15	Ring-Shaped Microlanes and Chemical Barriers as a Platform for Probing Single-Cell Migration Scientific Reports ·Christoph Schreiber, Felix J. Segerer, Ernst Wagner, Andreas Roidl, Joachim O. Rädler	2016	15
16	Downregulation of GRK5 hampers the migration of breast cancer cells Scientific Reports ·Ann‐Katrin Sommer, Mathias Falcenberg, Bojan Ljepoja, Thomas Fröhlich, Georg J. Arnold, Ernst Wagner, Andreas Roidl	2019	14
17	Synergistic Combination of Calcium and Citrate in Mesoporous Nanoparticles Targets Pleural Tumors Chem ·Constantin von Schirnding, Ioanna Giopanou, Adam Hermawan, Lisa Wehl, Giannoula Ntaliarda, Bernhard Illes, Stefan Datz, Franz Geisslinger, Karin Bartel, Ann‐Katrin Sommer, Marina Lianou, Veronika Weiß, Johann M. Feckl, Angelika M. Vollmar, Christoph Bräuchle, Georgios T. Stathopoulos, Ernst Wagner, Andreas Roidl, Thomas Bein, Hanna Engelke	2020	13
18	De-targeting by miR-143 decreases unwanted transgene expression in non-tumorigenic cells Gene Therapy ·Florian Kopp, Maria Schnoedt, Rudolf Haase, Ernst Wagner, Andreas Roidl, Manfred Ogris	2013	13
19	A proteomic analysis of chemoresistance development via sequential treatment with doxorubicin reveals novel players in MCF‑7 breast cancer cells International Journal of Molecular Medicine ·Ann‐Katrin Sommer, Adam Hermawan, Bojan Ljepoja, Thomas Fr�hlich, Georg J. Arnold, Ernst Wagner, Andreas Roidl	2018	13
20	Sequential Salinomycin Treatment Results in Resistance Formation through Clonal Selection of Epithelial-Like Tumor Cells Translational Oncology ·Florian Kopp, Adam Hermawan, Prajakta Oak, Vijay K. Ulaganathan, Annika Herrmann, Nefertiti El-Nikhely, Chitra Thakur, Zhiguang Xiao, Pjotr Knyazev, Beyhan Ataseven, Rajkumar Savai, Ernst Wagner, Andreas Roidl	2014	10

About Andreas Roidl

Andreas Roidl is a scholar working on Cancer Research, Toxicology, Molecular Biology, Oncology and Cell Biology, having authored 27 papers that have together received 817 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Cancer Cells and Metastasis (7 papers), RNA Interference and Gene Delivery (4 papers), Cancer-related molecular mechanisms research (3 papers), Circular RNAs in diseases (3 papers), Kruppel-like factors research (2 papers), Mechanisms of cancer metastasis (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (247 citations), Molecular Biology (636 citations), Oncology (206 citations), Toxicology (14 citations) and Cell Biology (55 citations). Andreas Roidl has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Ernst Wagner, Florian Kopp, Prajakta Oak, Adam Hermawan, Wolfhard Bandlow, Pjotr Knyazev, Axel Ullrich, Sushil Kumar, Johannes Bange and Georg J. Arnold. Their work appears in journals such as Scientific Reports, Translational Oncology, Oncotarget, International Journal of Cancer and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact